Kamran Alam

Kamran Alam

Chief Financial OfficeratTaysha Gene Therapies· In proxies 2022–2025

Pay in FY2024+158% from the year before · Taysha Gene Therapies stock -2.3% the same year

Kamran Alam was paid $2.5M in FY2024 (Dec), up 158%. Taysha Gene Therapies stock fell 2.3% that year.

Pay$100 in the stock at the end of FY21 → $15
Pay is from the Summary Compensation Table of each Taysha Gene Therapies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Taysha Gene TherapiesPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?